Fenland Study
The Fenland Study aims to investigate the interaction between environmental and genetic factors in determining obesity, type 2 diabetes, and related metabolic disorders. The study is a cohort of over 2,000 participants born between 1950 and 1975 (aged 30 to 62 years at recruitment) who have undergone detailed metabolic phenotyping with quantitative assessment of total and regional adiposity, diet and physical activity. Participants were recruited from 2005 to 2015 from participating general practice surgeries in the Cambridge, Ely and Wisbech areas in the United Kingdom. Phase 1 of the study was completed in 2015, Phase 2 in 2020 and Phase 3 in 2025. There have been a number of sub-studies, including a COVID-19 study from 2020 to 2021.
Study design
Cohort
Number of participants at first data collection
12,435 (participants)
Age at first data collection
Varied (participants)
Participant year of birth
1950 - 1975 (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Countries
Year of first data collection
2005
Primary Institutions
University of Cambridge (Academic, United Kingdom)
Profile paper DOI
Funders
Medical Research Council (MRC) (Research council, United Kingdom)
Ongoing?
Yes
Data types collected
- Activity log (e.g. food, sleep, exercise)
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Self-completed questionnaire – online
- Wearable devices
- None
- None
- Healthcare data
Engagement
Keywords
